-
Mashup Score: 2Let Doctors Deal With the Cancer Stats - 3 day(s) ago
When I was diagnosed and treated for a recurrence of AML, I was given an abundance of statistical information through required medical expert orations and accredited literature.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 14FLT3 Gene Cluster Expression, Not FLT3 Mutation Status Predicts Quizartinib Response in AML | Blood Cancers Today - 12 day(s) ago
Benefit from treatment with quizartinib was accurately predicted by a “FLT3-like” gene expression signature identified in patients with acute myeloid leukemia.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 9Low-Dose Azacitidine Plus Venetoclax Is Effective Maintenance for AML | Blood Cancers Today - 21 day(s) ago
Low-dose azacitidine plus venetoclax was a feasible maintenance regimen in AML after intensive or low-intensity induction therapy.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1
Cellular therapies are an effective option in hematologic malignancies but have been slower to develop in AML, but identifying new targets paves the way for evolving treatments.
Source: www.targetedonc.comCategories: General Medicine News, Onc News and JournalsTweet-
Cellular therapies have emerged as effective treatments for hematologic malignancies, yet progress in applying them to #AML lags behind. However, identifying new targets is driving innovation. @Daver_Leukemia @MusaYilmazMD @MDAndersonNews @StJudeResearch https://t.co/4qm32wr2l8 https://t.co/8ArowVHKCr
-
-
Mashup Score: 3MRD Appears Optimal for Allogeneic Transplant Patient Selection in AML | Blood Cancers Today - 22 day(s) ago
MRD status after induction chemotherapy predicted benefit from allogeneic transplant in patients with NPM1-mutated AML.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet-
✅ MRD status after induction chemotherapy predicted benefit from allogeneic transplant in patients with NPM1-mutated #AML in first complete remission. Read more about the study, led by Jad Othman, MD, of @NthSydHealth, and published in @BloodJournal. 📖 https://t.co/xsjpO0uU7A https://t.co/PXLrcYMRpy
-
-
Mashup Score: 3My ‘Other Birthday’ is Coming Up After Cancer - 24 day(s) ago
What it’s like having a “second birthday” after receiving a bone marrow transplant for my AML.
Source: www.curetoday.comCategories: General Medicine News, NursingTweet
-
Mashup Score: 0Novel Duplex Sequencing Assay Improves Detection of MRD in AML | Blood Cancers Today - 24 day(s) ago
The novel DuplexSeq AML-XP next-generation sequencing assay was highly accurate for detecting MRD in AML.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
-
Mashup Score: 1Acute Myeloid Leukemia | Blood Cancers Today - 27 day(s) ago
Acute myeloid leukemia (AML), the most common acute leukemia in adults, can occur when myeloid cells form abnormal myeloblast instead of developing into normal mature blood cells.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet
-
Mashup Score: 5Novel AML Therapy, Pivekimab Sunirine, Shows Promising Anticancer Activity | Blood Cancers Today - 1 month(s) ago
Monotherapy with pivekimab sunirine demonstrated activity in patients with relapsed or refractory CD123-positive AML.
Source: bloodcancerstoday.comCategories: General Medicine News, Hematologists1Tweet-
The novel therapy pivekimab sunirine demonstrated promising anticancer activity in patients with relapsed or refractory CD123-positive #AML, according to a study led by @Daver_Leukemia, of @MDAndersonNews, and published in @TheLancetOncol. 📰 Learn more: https://t.co/e71I6SFHp6 https://t.co/NKobx4uGLw
-
-
Mashup Score: 4ASTX727 Plus Venetoclax Is a Safe Regimen in Older Patients With AML | Blood Cancers Today - 1 month(s) ago
The ORR was 64% in the frontline cohort and 46% in the relapsed or refractory cohort.
Source: bloodcancerstoday.comCategories: General Medicine News, Partners & KOLsTweet
CURE® blogger Mary, a two-time #AML survivor, found out that her cancer is one of the top 10 deadliest cancers, but she emphasized that statistics are just statistics. Read Mary's blog, "Let Doctors Deal With the Cancer Stats," here: https://t.co/wJxSrARafl. https://t.co/2dGrsBvxaL